Page 68 - TequioVol1No2

66 Los virus /López y Gabriel/57-67

International Agency for Research on Cancer. (2011). repair complex to modulate an innate immune
Monographs on the Evaluation of Carcinogenic signaling pathway and viral latency. PLoS Pathog.,
Risks to Humans. A Review of Carcinogen Part 13(4), e1006335.
B: Biological Agents. Lyon, France: International
Agency for Research on Cancer. Matsuoka, M. y Jeang, K. T. (2007). Human T-cell
leukaemia virus type 1 (HTLV-1) infectivity and
Judson, H., et al. (1994). Basic genetic mechanisms. cellular transformation. Nat Rev Cancer, 7(4), 70-
In Molecular Biology of the Cell (pp. 273-287). 3rd 280.
ed. New York: Garland Science.
McGivern, D. R. y Lemon, S. (2009). Tumor
K Munger, H. P. (2002). Human papillomavirus suppressors, chromosomal instability and hepatitis
immortalization and transformation functions Virus C virus-associated liver cancer. Annual review of
Res. Virus Res., 89, 213-228. pathology, 4, 399-415.

Kajiya, Y., Hamasaki, K., Nakata, K., Miyazoe, S., Munakata, T., Nakamura, M., Liang, Y., Li, K. y Lemon,
Takeda, Y., Higashi, S., Ohkubo, K., Ichikawa, T., Nakao, S. M. (2005). Down-regulation of the retinoblastoma
K., Kato, Y. y Eguchi, K. (2001). A long-term follow- tumor suppressor by the hepatitis C virus NS5B
up analysis of serial core promoter and precore RNA-dependent RNA polymerase. Proc Natl Acad
sequences in Japanese patients chronically infected Sci USA, 102(50), 18159-18164.
by hepatitis B virus. Dig Dis Sci, 46(3), 509-515.
Parkin, D. M. (2006). The global health burden of
Knudson, A. G. Jr. (1971). Mutation and cancer: infection-associated cancers in the year 2002. Int J
statistical study of retinoblastoma. Proc Natl Acad Cancer, 118, 3030-3044.
Sci USA, 68, 820-823.
Plummer, M., De Martel, C., Vignat, J., Ferlay, J., Bray,
Levine, A. J. ( 2009). The common mechanisms of F. y Franceschi, S. (2016). Global burden of cancers
transformation by the small DNA tumor viruses: The attributable to infections in 2012: a synthetic
inactivation of tumor suppressor gene products: analysis. Lancet Glob Health, 4(9), e609-16.
p53. Virology, 384, 285-293.
Poynard, T., Man-Fung, Y., Vlad, R. y Ching Lung,
Litwin, T. R., Clarke, M. A., Dean, M. y Wentzensen, L. (2003). Viral hepatitis C. Lancet, 362, 2095-
N. (2017). Somatic Host Cell Alterations in HPV 2100.
Carcinogenesis. Viruses, 9(8), 206.
Rowe, M., Peng-Pilon, M., Huen, D. S., Hardy, R.,
Lok, A. S. (2004). Prevention of hepatitis B virus- Croom-Carter, D., Lundgren, E. y Rickinson A. B.
related hepatocellular carcinoma. Gastroenterology, (1994). Upregulation of bcl-2 by the Epstein-Barr
127, S303-9. virus latent membrane protein LMP1: a B-cell-
specific response that is delayed relative to NF-
Lowy, D. R. y Schiller, J. (2012). Reducing HPV- kappa B activation and to induction of cell surface
associated cancer globally. Cancer Prev. Res., 5, 18-23. markers. J Virol, 68(9), 5602-5612.

Madkan, V., Cook-Norris, R. H., Steadman, M. C., Arora, Seeger, C. y Mason, W. S. ( 2000). Hepatitis B virus
A., Mendoza, N. y Tyring, S. K. (2007). The oncogenic biology. Microbiol Mol Biol Rev., 64(1), 51-68.
potential of human papillomaviruses: a review on the
role of host genetics and environmental cofactors. Shackelford, J. y Pagano, J. S. (2004). Tumor
Br J Dermatol, 157(2), 228-241. viruses and cell signaling: Deubiquitination versus
ubiquitination. Mol Cell Biol., 24, 5089-5093.
Mariggiò, G., Koch, S., Zhang, G, Weidner-Glunde,
M., Rückert, J., Kati, S., Santag, S. y Schulz, T. F. Stewart, B. W. (2008). Banding carcinogenic
(2017). Kaposi Sarcoma Herpesvirus (KSHV) risks in developed countries: A procedural basis
Latency-Associated Nuclear Antigen (LANA) recruits for qualitative assessment. Mutat Res., 658,
components of the MRN (Mre11-Rad50-NBS1) 124-151.

Tequio, vol. 1, no. 2, enero-abril, 2018